logo
  

EnPro Industries Q3 Loss Widens - Quick Facts

EnPro Industries Inc. (NPO) reported Tuesday that its net loss for the third quarter widened to $19.7 million or $0.96 per share from net loss of $1.5 million or $0.08 per share in the year-ago period.

Excluding items, adjusted earnings from continuing operations were $0.67 per share, compared to $0.73 per share in the prior-year period.

However, net sales for the quarter declined 10.3 percent to $268.3 million from $299.0 million in the prior-year quarter.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.31 per share for the quarter on revenues of $214.6 million. Analysts' estimates typically exclude special items.

For fiscal 2020, EnPro Industries projects a year-over-year sales decline of a little over 15 percent and adjusted EBITDA margins of about 15 percent. This compares to the prior scenario planning ranges of a 15 percent to 25 percent decline in sales and adjusted EBITDA margins of 13 percent to 14 percent.

The Street expects earnings of $1.61 per share for the year on a 20.7 percent decrease in sales to $955.87 million.

EnPro noted that its two-year, $50 million share repurchase authorization initiated in October 2018 has now expired. The company's board approved a new share repurchase program, which runs to October 31, 2022, whereby the company may repurchase up to $50 million of shares in both open market and privately negotiated transactions.

EnPro added that its dividend policy remains unchanged and the company paid a quarterly dividend of $0.26 per share during the third quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration approved Regeneron Pharmaceuticals, Inc.'s Dupixent (dupilumab) to treat eosinophilic esophagitis or EoE, a chronic immune disorder. It is the first FDA approval to treat EoE in adults and pediatric patients 12 years and older weighing at least 40 kilograms. Food products maker J. M. Smucker Co. has recalled select Jif peanut butter products sold in the United States due to potential Salmonella contamination, the U.S. Food and Drug Administration said. The recall involves various creamy, crunchy, natural, no added sugar, and reduced fat peanut butter, among others with lot codes 1274425 - 2140425. Smithfield Packaged Meats Corp. is recalling around 185,610 pounds of ready-to-eat or RTE bacon topping products citing the possible contamination with extraneous materials, specifically metal, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced.
RELATED NEWS
Follow RTT